DNA GTx’s PIK3CA Test detects five clinically significant mutations in the PIK3CA gene, known to play a key role in the development and progression of various cancers, including breast and colorectal cancers. Identifying these somatic mutations can guide treatment selection, particularly the use of PIK3CA-targeted therapies, and support informed, personalized care planning.
Yes. A healthcare provider must request this test to ensure proper interpretation and use of the results in your care.
Let’s Decode the Future of Health — Together
Get in touch today — let’s start a conversation that could change lives
*All information is handled with strict confidentiality.
Find Answers Today
Early detection saves lives
*All information is handled with strict confidentiality.